Can-Fite BioPharma Ltd. Securities Received as Collateral
Can-Fite BioPharma Ltd. (CANF) had Securities Received as Collateral of $1.50 thousand as of 2022-12-31, per its 20-F filed 2023-03-30.
Discontinued › Balance Sheet › Assets
us-gaap:SecuritiesReceivedAsCollateral · last filed 2023-03-30
- 2022-12-31: Securities Received as Collateral $1.50K.
- 2019-12-31: Securities Received as Collateral $750.00.
| Period end | Securities Received as Collateral |
|---|---|
| 2022-12-31 | $1.50K 20-F · filed 2023-03-30 |
| 2019-12-31 | $750.00 20-F · filed 2023-03-30 |